NCT04656665

The Effectiveness of Aspirin on Preventing Pre-eclampsia

The Effectiveness of Low-dose Aspirin on Preventing Pre-eclampsia in High-risks Pregnant Women

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 600 (estimated)
• Sponsor: The Third Affiliated Hospital of Guangzhou Medical University · Academic / Other
• Sex: Female
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study will explore the effectiveness of low-dose aspirin on preventing pre-eclampsia in high-risks pregnant women by comparing the incidence of pre-eclampsia and pregnancy outcomes.

Detailed description

Currently，low-dose aspirin is a commonly used drug to prevent pre-eclampsia. Many guidelines recommend starting low-dose aspirin in early pregnancy in high-risks pregnant women. However, the applicable population and use method of aspirin are still controversial in clinical practice. This study will explore the effectiveness and use method of low-dose aspirin by comparing the incidence of pre-eclampsia and pregnancy outcomes.

Conditions

• Pre-Eclampsia

Interventions

Type	Name	Description
DRUG	Aspirin	For patients at high risk of pre-eclampsia, start taking aspirin from 12-20 weeks of pregnancy

Timeline

• Start date: 2021-03-15
• Primary completion: 2022-12-14
• Completion: 2022-12-31
• First posted: 2020-12-07
• Last updated: 2021-03-10